Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?

Risk of Mycobacterial Infections Associated With Rheumatoid Arthritis in Ontario, Canada

(2014) Sarah K. Brode et al.   CHEST

Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden

(2013) P. Raaschou et al.   BMJ-British Medical Journal

You can't always get what you want, but if you try sometimes (with two tests—TST and IGRA—for tuberculosis) you get what you need: Figure 1

(2012) Kevin L Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions

(2012) S Kleinert et al.   ANNALS OF THE RHEUMATIC DISEASES

Mycobacterial diseases and antitumour necrosis factor therapy in USA

(2012) KL Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization

(2012) Marie E. Holmqvist et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessing the safety of biologic agents in patients with rheumatoid arthritis

(2012) A. Rubbert-Roth   RHEUMATOLOGY

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

(2012) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register

(2010) M. Neovius et al.   ANNALS OF THE RHEUMATIC DISEASES

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

(2010) I. Solovic et al.   EUROPEAN RESPIRATORY JOURNAL

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009

(2009) D E Furst et al.   ANNALS OF THE RHEUMATIC DISEASES

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

(2009) W. G. Dixon et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry

(2009) F. Tubach et al.   ARTHRITIS AND RHEUMATISM